TAPBP
protein-codingTAP binding protein, the group of C1-set domain containing
Gene summary
This gene encodes a transmembrane glycoprotein which mediates interaction between newly assembled major histocompatibility complex (MHC) class I molecules and the transporter associated with antigen processing (TAP), which is required for the transport of antigenic peptides across the endoplasmic reticulum membrane. This interaction is essential for optimal peptide loading on the MHC class I molecule. Up to four complexes of MHC class I and this protein may be bound to a single TAP molecule. This protein contains a C-terminal double-lysine motif (KKKAE) known to maintain membrane proteins in the endoplasmic reticulum. This gene lies within the major histocompatibility complex on chromosome 6. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~14.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0971006
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011476
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011476
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0011476
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0011476
Submitter: ClinGen
A TAPBP germline loss of function variant was first identified in a woman with type I bare lymphocyte syndrome (BLS) (PMID: 12149238), the only report of a germline TAPBP variant. Other somatic TAPBP variants have been identified in cancers. Autosomal recessive TAPBP deficiency was associated with reduction of class I MHC expression and reductions in CD8 T cell and NK cell numbers in peripheral blood. Herpes zoster infection was noted in this adult patient, but no other immune deficiency was noted. This phenotype contrasts with type I BLS due to biallelic loss of function variants in TAP1, where patients show respiratory inflammation and skin ulcers. The indel variant identified in the single patient resulted in the loss of exon 4-7 of TAPBP, resulting in loss of expression of the protein and loss of function. Heterozygous carriers have not been reported in the literature. TAPBP plays a critical role in the peptide loading and resultant stable expression of cell surface MHC class I. In vitro data show that TAPBP is found in a complex with TAP1, TAP2, MHC, ERp57, and calreticulin, and is required for expression of class I MHC on the surface of cell lines (PMID: 9271576). Studies of cancer cell lines have found that variants in TAPBP reduce the expression of MHC class I on the surface of cells, potentially as a mechanism of immune evasion (PMID: 26381407). Class I MHC expression in these cell lines can be rescued with the transfection of WT TAPBP (PMID: 26381407). TAPBP knockout mice recapitulate the phenotype seen in the reported patient, with loss of stable class I MHC expression and reduced CD8 T cells (PMID:10973281, 12594855). TAPBP KO mice also show alterations in NK cell function and the ability of dendritic cells to cross-present antigens (PMID:10973281). TAPBP heterozygous KO mice show normal expression of MHC I (PMID: 10973281). While there is no evidence against the gene-disease relationship of TAPBP and type I BLS, there was only one patient identified that supports the relationship. Based on this,TAPBP has limited association with type I bare lymphocyte deficiency. This classification was originally approved by the ClinGen SCID-CID GCEP on 10/20/2022 (SOP Version 9). It was re-evaluated on June 19th, 2025 with no additional cases identified. Therefore, there is no change in this gene disease relationship.
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: Although the described individual did not have the same types of infections as other individuals with TAP deficiency, antiinfectious prophylaxis and early and aggressive treatment of infections may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TAPBP variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003190.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 93 | 6 | 102 | ||
| missense | 195 | 13 | 1 | 209 | ||
| nonsense | 1 | 7 | 8 | |||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 15 | 17 | |||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 0 | 3 | 233 | 106 | 7 | 349 |
Highest pathogenic variant AF is 0.00018970485
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003181.3 | 8 | MANE Select | |
| Ensembl | ENSP00000395701.2 | 8 | MANE Select | |
| RefSeq | NP_001397804.1 | 7 | Standard | |
| RefSeq | NP_757345.2 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Antigen processing and presentation - Homo sapiens (human)
- Immune System
- Adaptive Immune System
- Antigen processing-Cross presentation
- Class I MHC mediated antigen processing & presentation
Biological Process
- MHC class Ib protein complex assembly
- antigen processing and presentation of peptide antigen via MHC class I
- antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent
- retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
- immune response
Molecular Function
- protein binding
- peptide antigen-transporting ATPase activity
- MHC class I protein binding
- peptide antigen binding
- TAP1 binding
Cellular Component
- Golgi membrane
- endoplasmic reticulum
- endoplasmic reticulum membrane
- integral component of membrane
- phagocytic vesicle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000426633
- Coding exons
- 7
- Length
- 14694
- Individuals with no LoFs
- 125637
- Homozygous LoFs
- 1
- Heterozygous LoFs
- 110
- Defined
- 125748
- p
- 0.000441
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.764 | 258 | 295 | 0.875 | 0.0000154 | 3156 |
| Missense (PolyPhen) | 81 | 97.312 | 0.83237 | 1081 | ||
| Synonymous | 0.977 | 113 | 127 | 0.890 | 0.00000677 | 1144 |
| Loss of Function | 0.949 | 15 | 19.5 | 0.768 | 0.00000105 | 182 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00037 | rare |
| Latino/Admixed American | 0.00078 | 0.00075 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000052 | 0.000046 | rare |
| European (Non-Finnish) | 0.00061 | 0.00058 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in the association of MHC class I with transporter associated with antigen processing (TAP) and in the assembly of MHC class I with peptide (peptide loading). {ECO:0000269|PubMed:10636848}.;
- Disease
- DISEASE: Bare lymphocyte syndrome 1 (BLS1) [MIM:604571]: A HLA class I deficiency. Contrary to bare lymphocyte syndromes type 2 and type 3, which are characterized by early-onset severe combined immunodeficiency, class I antigen deficiencies are not accompanied by particular pathologic manifestations during the first years of life. Systemic infections have not been described. Chronic bacterial infections, often beginning in the first decade of life, are restricted to the respiratory tract. {ECO:0000269|PubMed:12149238}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.977
- RVIS EVS
- 0.13
- RVIS percentile EVS
- 63.49
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.992
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |